No evidence for human papillomavirus in the etiology of colorectal polyps

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 10, 2011, Pages 2288-2292

  Burnett Hartman, Andrea N ^a   Newcomb, Polly A ^a   Mandelson, Margaret T ^a   Galloway, Denise A ^a   Madeleine, Margaret M ^a   Wurscher, Michelle A ^a   Carter, Joseph J ^a   Makar, Karen W ^a   Potter, John D ^a   Schwartz, Stephen M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLON POLYP; COLORECTAL ADENOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RECTUM POLYP; RISK ASSESSMENT; VIRUS DETECTION; WART VIRUS;

ADENOMA; ADULT; AGED; ANTIBODIES, VIRAL; BLOTTING, SOUTHERN; CASE-CONTROL STUDIES; COHORT STUDIES; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; RISK FACTORS;

EID: 80053490339     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0450     Document Type: Article

References (50)

1. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000;19:1-5.
2. Steenbergen RD, De Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005;32 Suppl 1:S25-33. (Pubitemid 40332586)
3. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. (Pubitemid 46740304)
4. zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-81.
5. Munoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27. (Pubitemid 36159887)
6. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:2375-83.
7. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-75. (Pubitemid 40270113)
8. Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, De Sanjose S. Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009;62:870-8.
9. Bodaghi S, Yamanegi K, Xiao SY, Da Costa M, Palefsky JM, Zheng ZM. Colorectal papillomavirus infection in patients with colorectal cancer. Clin Cancer Res 2005;11:2862-7. (Pubitemid 40525184)
10. Buyru N, Tezol A, Dalay N. Coexistence of K-ras mutations and HPV infection in colon cancer. BMC Cancer 2006;6:115.
11. Cheng JY, Sheu LF, Lin JC, Meng CL. Detection of human papillomavirus DNA in colorectal adenomas. Arch Surg 1995;130:73-6.
12. McGregor B, Byrne P, Kirgan D, Albright J, Manalo P, Hall M. Confirmation of the association of human papillomavirus with human colon cancer. Am J Surg 1993;166:738-40; discussion 741-2.
13. Perez LO, Abba MC, Laguens RM, Golijow CD. Analysis of adenocarcinoma of the colon and rectum: detection of human papillomavirus (HPV) DNA by polymerase chain reaction. Colorectal Dis 2005;7:492-5. (Pubitemid 41223144)
14. Lee YM, Leu SY, Chiang H, Fung CP, Liu WT. Human papillomavirus type 18 in colorectal cancer. J Microbiol Immunol Infect 2001;34:87-91. (Pubitemid 32641337)
15. Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP, et al. Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 2007;33:569-74. (Pubitemid 46746534)
16. Deschoolmeester V, Van Marck V, Baay M, Weyn C, Vermeulen P, Van Marck E, et al. Detection of HPV and the role of p16INK4A over-expression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer 2010;10:117.
17. Perez LO, Barbisan G, Ottino A, Pianzola H, Golijow CD. Human papillomavirus DNA and oncogene alterations in colorectal tumors. Pathol Oncol Res 2010;16:461-8.
18. Koulos J, Symmans F, Chumas J, Nuovo G. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol 1991;4:58-61.
19. Shah KV, Daniel RW, Simons JW, Vogelstein B. Investigation of colon cancers for human papillomavirus genomic sequences by polymerase chain reaction. J Surg Oncol 1992;51:5-7.
20. Shroyer KR, Kim JG, Manos MM, Greer CE, Pearlman NW, Franklin WA. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma. Arch Surg 1992;127:741-4.
21. Gornick MC, Castellsague X, Sanchez G, Giordano TJ, Vinco M, Greenson JK, et al. Human papillomavirus is not associated with colorectal cancer in a large international study. Cancer Causes Control 2010;21:737-43.
22. Yavuzer D, Karadayi N, Salepci T, Baloglu H, Dabak R, Bayramicli OU. Investigation of human papillomavirus DNA in colorectal carcinomas and adenomas. Med Oncol. 2010;28:127-32.
23. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-30. (Pubitemid 44953403)
24. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009;4:343-64.
25. Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut 2007;56:1585-9. (Pubitemid 350033198)
26. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138-41. (Pubitemid 23098782)
27. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol 2001;25:177-84. (Pubitemid 32167499)
28. Jass JR. Serrated route to colorectal cancer: back street or super highway? J Pathol 2001;193:283-5. (Pubitemid 32229857)
29. Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 2004;53:1137-44. (Pubitemid 38961968)
30. O'Brien MJ. Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 2007;36:947-68, viii. (Pubitemid 350064454)
31. Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?Cancer Epidemiol Biomarkers Prev 2002;11:1012-8. (Pubitemid 35192651)
32. Wallace K, Grau MV, Ahnen D, Snover DC, Robertson DJ, Mahnke D, et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 2009;18:2310-7.
33. Ji BT, Weissfeld JL, Chow WH, Huang WY, Schoen RE, Hayes RB. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 2006;15:897-901. (Pubitemid 43823515)
34. Shrubsole MJ, Wu H, Ness RM, Shyr Y, Smalley WE, Zheng W. Alcohol drinking, cigarette smoking, and risk of colorectal adenomatous and hyperplastic polyps. Am J Epidemiol 2008;167:1050-8. (Pubitemid 351601236)
35. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007;7:11-22. (Pubitemid 46020844)
36. Salit IE, Tinmouth J, Chong S, Raboud J, Diong C, Su D, et al. Screening for HIV-associated anal cancer: correlation of HPV geno-types, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev 2009;18:1986-92.
37. Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, et al. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000;181:1911-9. (Pubitemid 30416152)
38. Ho GY, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004;13:110-6. (Pubitemid 38116628)
39. Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, et al. Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007;16:2697-703. (Pubitemid 351196326)
40. Adams SV, Newcomb PA, Burnett-Hartman AN, White E, Mandelson MT, Potter JD. Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer 2011;63:319-26.
41. Chung SM, Chen YT, Panczykowski A, Schamberg N, Klimstra DS, Yantiss RK. Serrated polyps with "intermediate features" of sessile serrated polyp and microvesicular hyperplastic polyp: a practical approach to the classification of nondysplastic serrated polyps. Am J Surg Pathol 2008;32:407-12. (Pubitemid 351398932)
42. Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, Runnebaum IB, et al. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol 2009;44:302-7.
43. Kleter B, Van Doorn LJ, ter Schegget J, Schrauwen L, Van Krimpen K, Burger M, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-9. (Pubitemid 28550661)
44. Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, et al. Multiplex human papillomavirus serology based on in situpurified glutathione S-transferase fusion proteins. Clin Chem 2005;51:1845-53. (Pubitemid 41368175)
45. Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002;186:1396-402. (Pubitemid 35286106)
46. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis 2009;200:1059-67.
47. Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, et al. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 2001;61:1934-40. (Pubitemid 32692010)
48. Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004;101:270-80. (Pubitemid 38890829)
49. Strickler HD, Schiffman MH, Shah KV, Rabkin CS, Schiller JT, Wacholder S, et al. A survey of human papillomavirus 16 antibodies in patients with epithelial cancers. Eur J Cancer Prev 1998;7:305-13. (Pubitemid 28473982)
50. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24Suppl 1:S1-15.